Similar Items: Heterogeneous trajectories of executive function in clinical Alzheimer's disease: Results from the 3C study
- CSF Biomarkers of Alzheimer’s Disease: Impact on Disease Concept, Diagnosis, and Clinical Trial Design
- Apathy and resting state functional connectivity across the Alzheimer's disease continuum
- Single‐subject proteomic signatures in Alzheimer's disease reflect clinical phenotypes and distinguish asymptomatic from symptomatic cases
- Alzheimer's disease drug development pipeline: 2026
- Features predicting data exclusion in imaging studies of Alzheimer's disease
- Atrophy signature for alpha‐synuclein copathology in Alzheimer's disease